Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Advanced Bio-Surfaces medial knee implant:

This article was originally published in Clinica

Executive Summary

The US FDA has given Advanced Bio-Surfaces (ABS) 510(k) clearance to sell its first orthopaedic product, a minimally-invasive medial knee implant for helping to replace some of the cartilage functions lost due to osteoarthritis. The OrthoGlide device, which was also recently approved in Europe, is made of cobalt-chrome and provides for positional stability without the use of rigid fixation methods. In addition, it features a specially contoured geometry that provides an open glide path, allowing for the unconstrained motion of the femoral condyle. Jeff Felt, the Minneapolis, Minnesota firm's chairman and CEO, said that other invasive treatments usually require extensive tissue and bone removal. "From a technology standpoint this has been an under-served area of orthopaedics. The introduction of OrthoGlide represents an excellent opportunity for ABS to capture a significant section of this expanding market."

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT050905

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel